Goss Wealth Management »

Anika Therapeutics shares owned by Goss Wealth Management

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Goss Wealth Management from 13F filings

Historical chart of Goss Wealth Management investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by Goss Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by Goss Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $139k 15k 9.61

More positions owned by Goss Wealth Management

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Ishares Core MF Closed and MF Open (IVV)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Alphabet Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
SPDR S&P MF Closed and MF Open (SPY)
Walmart Common Stock (WMT)
Berkshire Hathaway Common Stock (BRK.B)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Meta Platforms Common Stock (META)
Visa Common Stock (V)

View all positions for Goss Wealth Management

Top funds holding Anika Therapeutics

BlackRock
Caligan Partners
Vanguard Group
Acadian Asset Management
Boothbay Fund Management
Renaissance Technologies
Capital Management Corporation
Dimensional Fund Advisors
State Street Corporation
Geode Capital Management
Jacobs Levy Equity Management
D. E. Shaw & Co
Trigran Investments
Goldman Sachs Group
Jane Street

View all funds holding Anika Therapeutics